Acute coronary syndromes complicated by symptomatic and asymptomatic heart failure: Does current treatment comply with guidelines?

American Heart Journal

Volumn 147, Issue 5, 2004, Pages 859-864

  Haim, Moti ^a,b   Battler, Alexander ^a,b   Behar, Solomon ^b,c   Fioretti, Paolo M ^d   Boyko, Valentina ^c   Simoons, Maarten L ^e   Hasdai, David ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

^d SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SYMPTOM; TREATMENT OUTCOME; TREATMENT PLANNING;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CORONARY ANGIOGRAPHY; EUROPE; FEMALE; GUIDELINE ADHERENCE; HEART FAILURE, CONGESTIVE; HOSPITAL MORTALITY; HUMANS; MALE; MEDITERRANEAN REGION; MIDDLE AGED; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES; STROKE VOLUME; SYNDROME;

EID: 3042811605     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2003.11.014     Document Type: Article

References (33)

1. Ali A.S., Rybicki B.A., Alam M., et al. Clinical predictors of heart failure in patients with first acute myocardial infarction. Am Heart J. 138:1999;1133-1139
2. de Gevigney G., Ecochard R., Rabilloud M., et al. Worsening of heart failure during hospital course of an unselected cohort of 2507 patients with myocardial infarction is a factor of poor prognosis the PRIMA study: Prise en charge de l'Infarctus du Myocarde Aigu. Eur J Heart Fail. 3:2001;233-241
3. O'Connor C.M., Hathaway W.R., Bates E.R., et al. Clinical characteristics and long-term outcome of patients in whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction development of a predictive model. Am Heart J. 133:1997;663-673
4. Vaur L., Danchin N., Genes N., et al. Epidemiology of myocardial infarction in France therapeutic and prognostic implications of heart failure during the acute phase. Am Heart J. 137:1999;49-58
5. Rott D., Behar S., Gottlieb S., et al. Usefulness of the Killip classification for early risk stratification of patients with acute myocardial infarction in the 1990s compared with those treated in the 1980s Israeli Thrombolytic Survey Group and the Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) Study Group. Am J Cardiol. 80:1997;859-864
6. Rott D., Behar S., Leor J., et al. Effect on survival of acute myocardial infarction in Killip classes II or III patients undergoing invasive coronary procedures. Am J Cardiol. 88:2001;618-623
7. Spencer F.A., Meyer T.E., Gore J.M., et al. Heterogeneity in the management and outcomes of patients with acute myocardial infarction complicated by heart failure the National Registry of Myocardial Infarction. Circulation. 105:2002;2605-2610
8. Wu A.H., Parsons L., Every N.R., et al. Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol. 40:2002;1389-1394
9. Hasdai D., Topol E., Kilaru R., et al. Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction lessons from 4 international fibrinolytic therapy trials. Am Heart J. 145:2003;73-79
10. Pfeffer M.A., Braunwald E., Moye L.A., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction results of the survival and ventricular enlargement trial: the SAVE Investigators. N Engl J Med. 327:1992;669-677
11. Ambrosioni E., Borghi C., Magnani B. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction the Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators. N Engl J Med. 332:1995;80-85
12. Borghi C., Ambrosioni E., Magnani B. Effects of the early administration of zofenopril on onset and progression of congestive heart failure in patients with anterior wall acute myocardial infarction the SMILE Study Investigators: Survival of Myocardial Infarction Long-term Evaluation. Am J Cardiol. 78:1996;317-322
13. Kober L., Torp-Pedersen C., Carlsen J.E., et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med. 333:1995;1670-1676
14. Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 342:1993;821-828
15. Dargie H.J. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction the CAPRICORN randomised trial. Lancet. 357:2001;1385-1390
16. A randomized trial of propranolol in patients with acute myocardial infarction, I: mortality results. JAMA 1982;247:1707-14
17. Chadda K., Goldstein S., Byington R., et al. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. Circulation. 73:1986;503-510
18. Ryan T.J., Antman E.M., Brooks N.H., et al. 1999 update ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol. 34:1999;890-911
19. Braunwald E., Antman E.M., Beasley J.W., et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002 summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation. 106:2002;1893-1900
20. Hunt S.A., Baker D.W., Chin M.H., et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 38:2001;2101-2113
21. Braunwald E., Antman E.M., Beasley J.W., et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 40:2002;1366-1374
22. Stafford R.S.R.D. The underutilization of cardiac medications of proven benefit, 1990 to 2002. J Am Coll Cardiol. 41:2003;56-61
23. Mark D.B., Naylor C.D., Hlatky M.A., et al. Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med. 331:1994;1130-1135
24. Pilote L., Califf R.M., Sapp S., et al. Regional variation across the United States in the management of acute myocardial infarction GUSTO-1 Investigators: Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. N Engl J Med. 333:1995;565-572
25. Rouleau J.L., Moye L.A., Pfeffer M.A., et al. A comparison of management patterns after acute myocardial infarction in Canada and the United States the SAVE investigators. N Engl J Med. 328:1993;779-784
26. Hasdai D.B.S., Wallentin L., Danchin N., et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J. 23:2002;1190-1201
27. Lev E.I., Battler A., Behar S., et al. Frequency, characteristics, and outcome of patients hospitalized with acute coronary syndromes with undetermined electrocardiographic patterns. Am J Cardiol. 91:2003;224-227
28. Emanuelsson H., Karlson B.W., Herlitz J. Characteristics and prognosis of patients with acute myocardial infarction in relation to occurrence of congestive heart failure. Eur Heart J. 15:1994;761-768
29. Spencer F.A., Meyer T.E., Goldberg R.J., et al. Twenty year trends (1975-1995) in the incidence, in-hospital and long-term death rates associated with heart failure complicating acute myocardial infarction a community-wide perspective. J Am Coll Cardiol. 34:1999;1378-1387
30. Hellermann J.P., Jacobsen S.J., Gersh B.J., et al. Heart failure after myocardial infarction a review. Am J Med. 113:2002;324-330
31. Cleland J.G., Swedberg K., Follath F., et al. The EuroHeart Failure survey programme a survey on the quality of care among patients with heart failure in Europe, I: patient characteristics and diagnosis. Eur Heart J. 24:2003;442-463
32. Komajda M.F.F., Swedberg K., Cleland J., et al. The EuroHeart failure survey programme a survey on the quality of care among patients with heart failure in Europe, II: treatment. Eur Heart J. 24:2003;464-474
33. Rott D., Behar S., Hod H., et al. Improved survival of patients with acute myocardial infarction with significant left ventricular dysfunction undergoing invasive coronary procedures. Am Heart J. 141:2001;267-276